CTRI/2025/01/078985尚未招募3 期
A Randomised Comparative clinical study to evaluate the efficacy of RaktaPradarahara Yoga (Churna) over Pushyanuga Churna in Raktapradara W.S.R to Menorrhagia.
Dr Preeti Autade1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月30日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Reducing Excessive Menstrual Bleeding
研究概览
简要总结
The Present Study titled "A Randomised Comparative Clinical Study To Evaluate The Efficacy of Raktapradarahara Yoga (Choorna) over Pushyanuga Choorna in Raktapradara W.S.R. to Menorrhagia" will be conducted on 60 patients with 2 groups each group having 30 patients each with mentioned objective and subjective criteria. One group will be treated with Raktapradarahara Yoga(Choorna) and another with Pushyanuga Choorna, each for 90 days. Assessment of the patient will be done before treatment and after treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients complaining of excessive menstrual bleeding a) Duration.
- •More than 5 Days/21-35 days b) Quantity.
- •More than Grade 2 Bleeding according to Pictorial Blood Assesement Scale (i.e. more than 3 pads per day). 2) Age between 15-40 years/ Married or Unmarried. 3) Patient excessive cyclic bleeding for atleast 3 consecutive cycles. 4) Patients with Acute and chronic Pelvic Inflammatory Disease. 5) Patients with Intra-Mural/Interstitial fibroids and Submucous fibroids.
排除标准
- •Patients present with bleeding due to Abortion, Pregnancy and Lactation will be excluded.
- •Patient with systemic and endocrine disorder interfering with the present study will be excluded like: Sexually Transmitted Diseases, Hyperthyroidism, Bleeding disorders, Tuberculosis.
- •Patients having Hb percentage 8 gm% or less than 8 gm%.
- •Patients with Intra Uterine Contraceptive Device and patients taking Oral Contraceptive Pills.
- •Patients taking Hormonal Replacement Therapy due to any cause.
- •Benign and malignant growth in the uterus.
- •Cases with pelvic pathology Ovarian Cyst, Endometriosis and Metorrhagia or Menometorrhagia.
- •Patients acquired Cervical Stenosis, Vaginal Atresia will be excluded.
- •Patients with Submucousal Uterine fibroid, Cervical fibroids, Polyps.
结局指标
主要结局
Reducing Excessive Menstrual Bleeding
时间窗: 90 days
次要结局
- Reducing other related symptoms like Adhoudar shoola and Katishula based on gradings given(90 days)
研究者
Dr Preeti Santosh Autade
Dr. N.A. MAGADUM AYURVEDIC MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTER, ANKALI-591213
研究点 (1)
Loading locations...
相似试验
尚未招募
2/3 期
To evaluate the efficacy of PIPPALIYUKT DASHMOOL KWATH in the management of Amavata in comparative with RASONADI KWATH.CTRI/2024/10/075601Tilak Ayurved Mahavidyalaya78
尚未招募
不适用
Shunti bilwa kashaya and tab doxinate effect in Garbhini ChardiCTRI/2025/10/096180Dr Yogita Kamlesh Yadav80
招募中
Phase 3 4
A Comparative Clinical Study To Evaluate The Efficacy Of Vatapatradi Lepa With And Without Ksheeradhuma In The Management Of AcneCTRI/2025/11/097701Dr Jigna Jayeshbhai Parmar40
尚未招募
Phase 3 4
A Study Comparing Ayurvedic Herbal Smoke Therapy and Oxygen Exposure Therapy For Faster Healing of Diabetic Foot UlcerCTRI/2025/11/097191Dr Jignesh Babubharthi Goswami32
尚未招募
不适用
Effect of Ayurvedic Enema Therapy and Herbal Tablets in Women with Uterine Fibroids.CTRI/2026/02/102780Dr Geetashree20